Circulation 2002 May 21;105(20):2398-403 - FAC

The selective phosphodiesterase-5 inhibitor sildenafil has been reported to cause pulmonary vasodilatation. Objective: To evaluate the safety and effectiveness of oral sildenafil, alone and in … ................
................